# A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)

> **NCT06172257** · PHASE3 · COMPLETED · sponsor: **Oculis** · enrollment: 401 (actual)

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** Dexamethasone ophthalmic suspension (OCS-01)
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT06172257
- **Lead sponsor:** Oculis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-15
- **Primary completion:** 2026-04-02
- **Final completion:** 2026-04-02
- **Target enrollment:** 401 (ACTUAL)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06172257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06172257, "A Pivotal Safety and Efficacy Study of OCS-01 Eye Drops in Participants With Diabetic Macular Edema (DIAMOND 2)". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT06172257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*